Associated factors with nonscarring alopecia in adult women, cross-sectional study carried out from January to December 2013
Abstract
Introduction. Alopecia refers to the pathological loss of hair in any form and within any place of the skin surface. This medical condition is divided into two large groups: cicatricial and nonscarring alopecia. Although the second type of Alopecia is a prevalent pathology, it has not been recorded among Latin- American population. Objective. To establish the prevalence and variables associated with alopecia that are relevant to the study population. Methodology. Analytical observational study that was carried out from January to December of 2013. This one reviewed 169 medical records of women over the age
of 18 that had nonscarring alopecia. The statistical analysis was made using EPI Info version 7. Results. The average age of the reviewed medical cases for this study was 38.5 and the estimated prevalence for nonscarring alopecia was 12.1%. 35.5% (IC 95% 28.31-43.22) was diagnosed as female pattern of hair loss; 19.53% (IC 95% 13.84-26.31) was diagnosed as mixed alopecia and alopecia areata, followed by chronic telogen effluvium with 17.16% (IC 95% 11.8-23.7). The great majority of patients had significant medical histories, mostly those associated with hypothyroidism with a 20.47% (IC 95% 13.8-28.5). Among the patients that were studied, the average rate for ferritin, thyrotropin and hemoglobin was 76.65 mcg/L, 3.08 ml U/L and 13.81 grams/dl respectively. The study showed a positive association between the alopecia type and ferritin rates (p < 0.0001). Conclusions. This study concludes that reduced rates of serum ferritin are related with telogen effluvium pathophysiology and that this condition does not occur in thyroid disorders. More studies are required in order to stablish variables associated with Colombia. [Cifuentes-Tang LI, Uribe-Caputi JC. Associated factors with nonscarring alopecia in adult women, cross-sectional study carried out from January to December 2013. MedUNAB. 2018;21(1):59-66.doi: 10.29375/01237047.2677].
References
Guerra A. La alopecia de la mujer. 5 ed. Madrid: Editorial Raíz; 2009.
Falabella R, Escobar C, Giraldo N. Dermatología Fundamentos de Medicina. 5 ed. Medellín, Colombia: Corporación para investigaciones biológicas; 2002.
Thiedke CC. Alopecia in Women. Am Fam Physician. 2003; 67(5):1007-14.
Herskovitz I, Tosti A. Female pattern hair loss. Int J Endocrinol Metab. 2013;11(4):e9860. doi: 10.5812/ijem.9860
Levy LL, Emer JJ. Female pattern alopecia: current perspectives. Int J Womens Health. 2013;5:541-56. doi: 10.2147/IJWH.S49337.
Malkud S. Telogen Effluvium: A Review. J Clin Diagn Res. 2015;9(9):WE01-03. doi:10.7860/JCDR/2015/15219.6492.
Headington JT. Telogen effluvium: New concepts and review. Arch Dermatol. 1993;129(3):356-63. doi: 10.1001/archderm.1993.01680240096017.
Harrison S, Sinclair R. Telogen Effluvium. Clin Exp Dermatol. 2002; 27(5):389-5. doi: 10.1046/j.1365-2230.2002.01080.x.
Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999;341(7):491-7. doi: 10.1056/NEJM199908123410706.
Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle aged women. J Am Acad Dermatol. 1996;35(6):899-906.
Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on Scid mice. J Clin Invest. 1998;101(1):62-7. doi: 10.1172/JCI551.
Bertolino AP. Alopecia areata. A clinical overview. Postgrad Med. 2000; 107(7):81-90. doi: 10.3810/pgm.2000.06.1111.
Vujovic A, Del marmol V. The female pattern hair loss: review of etiopathogenesis and diagnosis. Biomed Res Int. 2014;2014:767628. doi: 10.1155/2014/767628.
Albarán C, Alejandro L, Chaparro A. Estudio descriptivo sobre la pérdida de cabello de patrón femenino en una consulta dermatológica general [Tesis]. Bogotá: Universidad del Rosario y CES; 2015. 75 p.
Werner B, Mulinari-Brenner F. Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata - part I. An Bras Dermatol. 2012; 87(5):742-47. doi: 10.1590/S0365-05962012000600010.
Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2003;121(5):985-88. doi: 10.7860/JCDR/2015/14089.6170.
Burman KD, McKinley-Grant L. Dermatologic aspects of thyroid disease. Clin Dermatol. 2006;24(4):247-55. doi: 10.1016/j.clindermatol.2006.04.010.
Freinkel RK, Freinkel N. Hair growth and alopecia in hypothyroidism. Arch Dermatol. 1972;106(3):349-52. doi: 10.1001/archderm.1972.01620120037007.
Moeinvaziri M, Mansoori P, Holakooee K, Safaee Naraghi Z, Abbasi A. Iron Status in Diffuse Telogen Hair Loss among Women. Acta Dermatovenerol Croat. 2009; 17(4):279-84.
Hard S. Non-anemic iron deficiency as an etiologic factor in diffuse loss of hair of the scalp in women. Acta Derm Venereol. 1963; 43:562-9.
Rushton DH, Ramsay ID, James KC, Norris MJ, Gilkes JJ. Biochemical and trichological characterization of difuse alopecia in women. Br J Dermatol. 1990;123(2):187-97. doi: 10.1111/j.1365-2133.1990.tb01846.x.
Van Neste DJ, Rushton DH. Hair problems in women. Clin Dermatol. 1997;15(1):113-25. doi: 10.1016/S0738-081X(96)00114-9.
White MI, Currie J, Williams MP. A study of the tissue iron status of patients with alopecia areata. Br J Dermatol. 1994; 130(2):261-63. doi: 10.1111/j.1365-2133.1994.tb02917.x.
Boffa MJ, Wood P, Griffiths CE. Iron sta.tus of patients with alopecia areata. Br J Dermatol. 1995;132(4):662-4. doi: 10.1111/j.1365-2133.1995.tb08727.x.
Downloads
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
